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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489 S323attenuates NF-kB signalling through at least inhibition of DNA binding
in HACs with attenuation of expression of several NF-kB dependent
genes. SFN abrogates cytokine-induced destruction of bovine nasal
cartilage at the level of both proteoglycan and collagen breakdown
(10mM compared to cytokines alone). It also decreases arthritis score in
the DMM murine model of osteoarthritis (3mmol daily dose SFN in diet
versus control chow).
Conclusions: SFN, at levels which can be obtained through a broccoli-
rich diet, inhibits the expression of key metalloproteinases implicated
in osteoarthritis independently of Nrf2 and blocks inﬂammation at the
level of NF-kB to protect against cartilage destruction in vitro and in
vivo. Ongoing studies in man will ascertain the potential of this com-
pound in human osteoarthritis.
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OSTEOARTHRITIS
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Purpose: Current pharmacological intervention for osteoarthritis (OA)
is focused on inﬂammation and pain relief rather than addressing the
degradation of articular cartilage. Such treatments typically have a
single mode of action in a multifactorial disease. Compounds present in
the habitual diet are as an attractive alternative, since foods typically
contain multiple bioactive compounds that can interact with multiple
cellular pathways. The purpose of this study was to identify novel
chondroprotective compounds from the habitual diet.
Methods: Since matrix metalloproteinase-13 (MMP-13) is considered a
key collagen-degrading enzyme, inhibition of MMP13 expression,
measured by qRT-PCR, was used as a surrogate marker of cartilage
degradation. Ninety-six diet derived compounds were selected from a
list of compounds based on (i) the edibility of the source; (ii) how
commonly it was consumed; (iii) whether the compound had pre-
viously been studied in chondrocytes. Compounds (at 10 mM) were
screened in triplicate against basal expression and inhibition of inter-
leukin-1 (IL-1)-induced expression of MMP13 in SW1353 chon-
drosarcoma cells and the C28/I2 immortalised human chondrocyte cell
line. The lead compounds from these screens were then assayed in
three isolates of primary human articular chondrocytes for their impact
on expression of MMP13, MMP1, ADAMTS4 and ADAMTS5. Compound
toxicity was measured using lactate dehydrogenase release and FACS.
Results: All compounds tested were non-toxic at 10mM. Six compounds
signiﬁcantly reduced IL-1-induced MMP13 expression in SW1353 cells,
whilst eleven compounds signiﬁcantly reduced IL-1-induced MMP13
expression in C28/I2 cells (p<0.05 - p<0.0001). Of these compounds
assayed in primary human articular chondrocytes, ﬁve compounds
signiﬁcantly inhibited both IL-1-induced MMP1 andMMP13 expression
(apigenin, aloe emodin, emodin, luteolin and isoliquiritigenin). Apige-
nin signiﬁcantly inhibited IL-1-induced ADAMTS5 and aloe emodin
signiﬁcantly inhibited IL-1-induced ADAMTS4 (p<0.05 - p<0.01). Api-
genin, aloe emodin and isoliquiritigenin showed dose-dependency
across the 2.5 - 40mM range.
Conclusions: This screen has identiﬁed a number of target compounds
which have the potential to be chondroprotective. Apigenin is a ﬂavone
found in various plants including celery and swede; aloe emodin is a
hydroxyanthraquinone found in aloe vera; isoliquiritigenin is a chal-
cone from licorice. These compounds will now be taken forwards for
further analyses.
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THE IN VITRO EFFECTS OF PROCYANIDINS AND HYDROXYTYROSOL-
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Purpose: Osteoarthritis (OA) is a major health concern that affects a
growing part of our aging population associated with strong socio-
economic burdens. To date, there is no curative treatment for OA.
Pharmaceutical drugs alleviate inﬂammation and pain but nonesucceeds to slow down, stop or reverse the progression of the cartilage
degradation and other adverse tissue injuries related to the pathology.
In the last decades, many studies tried to demonstrate the effectiveness
of herbal medicines to treat OAwithout the side effects associated with
pharmacological treatments. This growing interest has led to the
emerging concept of nutraceuticals. Among these nutraceuticals, phe-
nolic phytochemicals compounds like procyanidins and hydroxytyrosol
are now well acknowledged for their potent antioxidant and anti-
inﬂammatory effects. There is, however, no scientiﬁc evidence to show
the efﬁcacy and safety of these compounds for OA prevention. In this
study, we examined the effects of a grape and olive extract mix (OPCO)
containing a high concentration of procyanidins and hydroxytyrosol on
the in vitro and ex vivo inﬂammation-associated OA events.
Methods: OPCO (Grapsud, France) was characterized for its procyani-
dins and hydroxytyrosol contents by vanillin method and HPLC. Human
articular choncrocytes (HAC), rabbit articular chondrocytes (RAC) and
cartilage explants were harvested from tibial plateau and femoral
condyles of 7 weeks-old New Zealand white rabbits and human
cadavers. Cell viability was evaluated with a Methyl tetrazolium salt
(MTS) assay. To mimick the inﬂammatory conditions of OA, cells were
treated with IL-1b (1ng/mL) for 24 and 48H and culture media were
then collected for nitric oxide (NO) and prostaglandin E2 (PGE2)
measurements. The NO production was investigated by the Griess
method, and PGE2 production was determined by Enzyme-linked
immunosorbent assay (ELISA). The nuclear translocation of NF-kB
(subunit p65) in HAC treated with IL-1b in the presence of OPCO was
investigated by immunoﬂuorescence using a speciﬁc antibody.
Results: Our results showed that OPCO contained 30% and 6.4% of
procyanidin and hydroxytyrosol, respectively. MTS assay indicated that
OPCO did not affect HAC and RAC viability. Our results also showed that
IL-1b treatment induced a 3.5, 8 and 9.5 fold increase in the NO pro-
duction in RAC, HAC and human explants, respectively. In addition, IL-
1b treatment triggered a 7-, 33- and 1300-fold increase in PGE2 pro-
duction in RAC, HAC and human explants, respectively. Interestingly, a
24H pretreatment of RAC, HAC and human explants with OPCO induced
a signiﬁcant reduction in the IL-1b-induced production of NO by 32%,
54%, and 60%, respectively. The IL-1b-dependent synthesis of PGE2 in
RAC, HAC and explants was also reduced by about 75%, 97%, and 97%,
respectively. Finally, whereas IL-1b was found to induce the nuclear
translocation of p65 NF-kB, OPCO was shown to inhibit the IL-1b-
induced nuclear translocation of p65 NF-kB in HAC.
Conclusions: In this study we have showed that a grape and olive
extract, containing high amount of procyanidin and hydroxytyrosol,
may carry out potent anti-inﬂammatory activities through the inhib-
ition of IL-1b-driven NO and PGE2 production. In addition, our results
strongly suggest that the anti-inﬂammatory activity of OPCO is likely to
be mediated at least through the inhibition of p65 NF-kB pathway.
Further in vivo experiments in adapted animal models of OA are now
under investigation to determine whether grape and olive extracts may
be promising nutraceuticals for the prevention of inﬂammation-asso-
ciated OA symptoms.
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Purpose: A major opportunity is represented by the search for food-
derived molecules able to interfere with the processes involved in the
pathogenesis or progression of chronic degenerative- and age-related
diseases, such as osteoarthritis (OA). Recent ﬁndings attributed a
potential role to autophagy in the regulation of the cellular response to
several stress stimuli. Although its role is context- and tissue-depend-
ent and still unclear, autophagy has been observed to decrease during
aging and several age-related diseases, including OA. Here we address
the question whether 3-hydroxytyrosol (HT) pre-treatment of chon-
drocyte cultures is able to reduce cell death, terminal chondrocyte
differentiation and matrix degradation induced by oxidative stress. This
natural compound is one of the major polyphenols present in olive oil
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ulatory effects on different signalling pathways.
Methods: The immortalized human cell line C-28/I2 and primary cul-
tures of human chondrocytes (prepared from fragments of articular
cartilage obtained from adult OA patients undergoing knee arthro-
plasty) were treated with HT, 30 minutes before exposition to hydrogen
peroxide to induce oxidative stress and samples were collected at dif-
ferent times. We tested cell viability through reading on MUSE Cell
Analyzer. The expression of genes and proteins known or potentially
implicated in OA was evaluated by Real-Time RT-PCR assay and by
Western blot method, respectively. By 6 different algorithms (TargetS-
can, miRanda, PICTAR4, miRDB, miRWalk, RNA22) bioinformatic anal-
ysis selected possible candidate microRNAs that could interact with
targets of interest. Subsequently we veriﬁed by Real Time RT-PCR assay
possible variations in the expression of these microRNAs after
treatments.
Results:We evaluated the gene expression of runt-related transcription
factor-2 and matrix metalloproteinase-13, two molecular markers of
OA, in human primary chondrocytes cultured in monolayer. HT pre-
vents the increase induced by oxidative stress in the mRNA amount of
bothmarkers. Moreover this compound is able to reduce signiﬁcantly C-
28/I2 cells death. In order to investigate a possible involvement of
autophagic process in this context, we evaluated the protein expression
of LC3 II (active form associated to autophagosomes), after oxidative
stress in presence or in absence of HT. We found that HT induces an
increase of protein levels of this autophagic marker, suggesting a pos-
sible mechanism of cytoprotection. This effect of HT on autophagy may
be promoted by modulating several effectors such as AMP-activated
protein kinase (AMPK) and the NAD-dependent deacetylase Sirtuin-1
(SIRT-1). Indeed HT causes the increase of phospho-AMPK and SIRT-1
protein levels. At the same time, this compound is able to decrease the
amount of microRNA-9, which can target SIRT-1mRNA thusmodulating
its expression.
Conclusions: This study suggests newmolecular mechanisms by which
HT may prevent some aspects of OA pathogenesis and progression.
Indeed the beneﬁcial action of HT in this context seems to be related to
the stimulation of autophagy. These data indicate that HT can be con-
sidered an attractive tool for the prevention of OA.This work was sup-
ported by FIRB (Ministero dell’istruzione, dell’Universita e della Ricerca,
Italy) grant RBAP10KCNS.
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EFFICACY AND SAFETY OF GINGER IN OSTEOARTHRITIS PATIENTS: A
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Purpose: To assess the clinical efﬁcacy and safety of oral ginger for
symptomatic treatment of osteoarthritis (OA).
Methods: A systematic literature search was undertaken in the biblio-
graphic databases: MEDLINE via PubMed from 1950, EMBASE via OVID
from 1980, CINAHL via EBSCO from 1981,Web of Science from 1900, and
Sciﬁnder from 1907, as well as The Cochrane Central Register of Con-
trolled Trials, all up to August 2013. Inclusion criteriawere: Randomized
trials comparing any oral ginger preparation (consisting only of extracts
of ginger species) with placebo, where the participants were aged 18 or
over with OA in any joint. Major outcomes were reduction in pain and
improvement in physical function. Harm was assessed as withdrawals
due to adverse events. The efﬁcacy effect size was estimated using
Hedges’ standardized mean difference (SMD) and safety using the risk
ratio (RR). Standard random-effects meta-analysis was used by default
(conﬁrmed by a ﬁxed-effects model), and inconsistency was evaluated
by the I-squared index (I2).
Results: Out of 113 retrieved references, 108 were discarded, leaving
ﬁve placebo-controlled trials (757 patients, mainly with knee and/or
hip OA) for the meta-analysis. The majority reported relevantrandomization procedures and blinding but applied an inadequate
intention-to-treat (ITT) approach. Pain reduction following ginger
intake revealed a low degree of heterogeneity among trials (I2 ¼ 27%),
with a statistically signiﬁcant SMD of -0.30 (95% CI: [-0.50, -0.09], P ¼
0.005) in favour of ginger. Ginger showed a statistically signiﬁcantly
larger improvement in physical function than placebo SMD¼ -0.22 (95%
CI: [-0.39, -0.04]; P¼ 0.01; I2¼ 0%). Based on data from three trials (328
patients), patients given ginger were more than twice as likely to dis-
continue treatment due to adverse events compared to placebo (RR ¼
2.33; 95% CI: [1.04, 5.22]; P ¼ 0.04; I2 ¼ 0%).
Conclusions: Ginger was found modestly efﬁcacious in reducing pain
and improve physical function in clinical trials of patients with mainly
knee and/or hip OA. Ginger was also reasonably safe since reported
adverse events were mild and reversible. We judged the evidence to be
of moderate quality, based on the small number of participants and
non-adequate ITT analysis (with the latter risk of bias item leading to
downgrading from high to moderate conﬁdence in the estimates).
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Purpose: Osteoarthritis (OA) is a signiﬁcant worldwide health problem
owing to the progressive and debilitating nature of the condition, which
results in highmorbidity and amarked decrease in the quality of life. OA
involves the progressive degeneration of articular cartilage with a
remodeling of subchondral bone and synovitis.
The objective is to evaluate the potential anti-arthritic activity of Acti-
Joint, a formulation that includes CS Bioactive (Chondroitin Sulfate
100% purity ,CS), Glucosamine (GLU) and Hyal-Joint, a natural ingre-
dient rich in sodium hyaluronate in an in vitro chondrocyte model and
in the collagen-induced arthritis (CIA) model in rats.
Methods: An in vitro study was performed using human osteoarthritic
chondrocytes cultured in alginate (n¼ 3) in order to evaluate the
potential chondroprotective activity of Acti-Joint. Effects on degra-
dation of the extracellular matrix were determined by measuring
metalloproteinase-1 (MMP-1) and metalloproteinase-13 (MMP-13)
activities by ELISA (R&D kits). The synthesis of sulfated glyco-
saminoglycans (GAGs) was measured in chondrocytes by determining
the incorporation of [35S]sulfate into cetylpyridiniumchloride-precip-
itable (CPC) GAGs by liquid scintillation analysis.
The anti-arthritic activity was investigated in the CIA model in rats.
Female rats with developing type II collagen arthritis (n ¼ 11) were
treated orally once daily with distilled water (Vehicle group) or Acti-
Joint (160 mg/kg) starting 10 days prior to disease induction through
the end of the study (day 35). Dexamethasone, the positive control
group, was administered once daily starting at day 0. The arthritic
clinical score for each animal was examined starting at day 7. A clinical
score was given to each individual paw and was based on 0-4 scale. The
sum of all paws was calculated for each animal. In addition, a cytokine
analysis on the left hind joint was performed: IL-6 and TNFa gene
expression.
Results: The in vitro assays showed that Acti-Joint leads to a stat-
istically signiﬁcant reduction of MMP-1 andMMP-13 activities (p<0.05)
and also a stimulation of the synthesis of GAGs compared to the Control.
Acti-Joint showed better efﬁcacy than the standard combination GLU
þ CS, being CS of a lower quality and uncertain traceability. In the
experimental conditions of the in vivo study, we found that this for-
mulation reduced about 10% the clinical score after 3 weeks of the
arthritis induction. This was accompanied by a signiﬁcant reduction of
the pro-inﬂammatory cytokines IL-6 (74%) and TNFa (70%) levels
compared to Vehicle group.
Conclusions: The present study indicates that Acti-Joint has chon-
droprotective and anti-inﬂammatory activities. Thus, this natural
